Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CVS Health Corp before investing.

In this article, we go over a few key elements for understanding CVS Health Corp’s stock price such as:

• CVS Health Corp’s current stock price and volume
• Why CVS Health Corp’s stock price changed recently
• Upgrades and downgrades for CVS from analysts
• CVS’s stock price momentum as measured by its relative strength

About CVS Health Corp (CVS)

Before we jump into CVS Health Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.

Want to learn more about CVS Health Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CVS Health Corp.

CVS Health Corp’s Stock Price as of Market Close

As of September 27, 2024, 3:59 PM, CST, CVS Health Corp’s stock price was $61.38.

CVS Health Corp is up 4.02% from its previous closing price of $59.01.

During the last market session, CVS Health Corp’s stock traded between $58.35 and $59.08. Currently, there are 1,256.00 million shares of CVS Health Corp stock available for purchase.

CVS Health Corp’s price-earnings (P/E) ratio is currently at 10.5, which is low compared to the Healthcare Facilities & Services industry median of 22.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

CVS Health Corp Stock Price History

CVS Health Corp’s (CVS) price is currently up 7.23% so far this month.

During the month of September, CVS Health Corp’s stock price has reached a high of $61.86 and a low of $54.81.

Over the last year, CVS Health Corp has hit prices as high as $83.25 and as low as $52.77. Year to date, CVS Health Corp’s stock is down 34.13%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused CVS Health Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 26, 2024, there was 1 analyst who downgraded CVS Health Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate CVS Health Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CVS Health Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

CVS Health Corp’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CVS Health Corp (CVS) by visiting AAII Stock Evaluator.

Relative Price Strength of CVS Health Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 26, 2024, CVS Health Corp has a weighted four-quarter relative price strength of -9.12%, which translates to a Momentum Score of 32 and is considered to be Weak.

Want to learn more about how CVS Health Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

CVS Health Corp Stock Price: Bottom Line

As of September 27, 2024, CVS Health Corp’s stock price is $61.38, which is up 4.02% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CVS Health Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.